Brian Jackson
Human Resources Officer at Jazz Pharmaceuticals UK Ltd.
Network origin in Brian Jackson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Jazz Pharmaceuticals UK Ltd.
Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Brian Jackson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | General Counsel | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
3I GROUP PLC | Investment Managers | Corporate Officer/Principal | |
Zeneus Pharma Ltd.
Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Medical Distributors | Comptroller/Controller/Auditor General Counsel | |
PAION AG | Pharmaceuticals: Major | Chief Executive Officer | |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO General Counsel Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
3I INFRASTRUCTURE PLC | Investment Managers | Director/Board Member | |
The Chartered Governance Institute
The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | General Counsel | |
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director of Finance/CFO | |
ALLIANCE PHARMA PLC | Pharmaceuticals: Major | Chairman | |
University of Oxford | College/University | Graduate Degree | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The British Standards Institution
The British Standards Institution Miscellaneous Commercial ServicesCommercial Services The British Standards Institution provides international standards, testing, registration, and certification for businesses. Its services include certification, compliance tools and software, developing new standards, events and conferences, product certification and standard subscription services. The firm serves in the areas of aerospace and aviation, automotive, construction, energy and utilities, food and drink, IT and telecom and medical devices industries. The company was founded by John Wolfe-Barry in 1901 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Imtix
Imtix Pharmaceuticals: OtherHealth Technology Part of Sanofi, Imtix is a French company that develops and markets pharmaceuticals for transplantation. The company is based in Lyon, France. The company was founded by Gilles Alberici. Imtix was acquired by SangStat Medical Corp. from Rhone-Poulenc SA on October 01, 1998 for $31 million. | Pharmaceuticals: Other | Founder | |
University of London | College/University | Undergraduate Degree | |
University of Birmingham | College/University | Undergraduate Degree | |
ACR Capital Holdings Pte. Ltd.
ACR Capital Holdings Pte. Ltd. Specialty InsuranceFinance ACR Capital Holdings Pte Ltd. engages in the provision of risk solutions and reinsurance services. It offers solutions in the business lines of agriculture; aviation; credit and surety; energy; and marine. The company was founded by Kwang Kherng Tan in 2006 and is headquartered in Singapore. | Specialty Insurance | Director/Board Member | |
3i Private Equity
3i Private Equity Investment ManagersFinance 3i Private Equity is a private equity firm, founded in 1945. The firm is headquartered in London, United Kingdom with additional offices around the world. | Investment Managers | Private Equity Investor | |
Tato Holdings Ltd.
Tato Holdings Ltd. Chemicals: Major DiversifiedProcess Industries Tato Holdings Ltd. manufactures and supplies specialty chemicals. The company was founded on October 2, 1996 and is headquartered in Canterbury, the United Kingdom. | Chemicals: Major Diversified | Director/Board Member | |
Power Integrations U.K. Ltd.
Power Integrations U.K. Ltd. SemiconductorsElectronic Technology Power Integrations UK Ltd. provides energy-efficient power conversion products. Its applications include mobile, feature, smart phones and media tablets. The company was founded by Gehan Anil Joseph Amaratunga and is headquartered in Cambridge the United Kingdom. | Semiconductors | Director/Board Member | |
Netronome Systems, Inc.
Netronome Systems, Inc. Electrical ProductsProducer Manufacturing Netronome Systems, Inc. designs and supplies flow processing silicon and software for cyber security applications. It offers its products for network analytics, software-defined networking, and cloud data center server virtualization. The firm’s solutions include cloud NFV infrastructure, data center IaaS Applications, openStack cloud networking, network security, data center SDN gateway, and express virtio-XVIO. The company was founded by Niel Viljoen, David Wells, and Johann Tönsing in 2003 and is headquartered in Cranberry Township, PA. | Electrical Products | Director/Board Member | |
QIAGEN MARSEILLE | Miscellaneous Commercial Services | Director/Board Member | |
Octalfa SAS
Octalfa SAS Investment ManagersFinance Octalfa SAS is a family-owned, independent private equity holding and investment company controlled by Gilles Alberici. Octalfa was established in 2006 and is based near Lyon in Eastern France. The firm manages a portfolio of participations in Life Sciences companies. They are also the key investor of Octalfa 360 Health and Green Technologies, a sector mutual fund invested in listed equity, co-managed by 360 Asset Managers SA and Xénia SARL (aka Xénia Gestion Privée). The fund focuses on sectors such as biotechnology and clean technology. Octalfa is committed to public health issues, and established the Dominique Alberici-Octalfa Corporate Foundation to support initiatives aimed at improving medical and paramedical care for cancer patients and the disabled. | Investment Managers | Chairman | |
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Chief Executive Officer | |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member | |
OTONOMY | Biotechnology | Director/Board Member | |
Merieux Group | Corporate Officer/Principal | ||
Cirtec Medical Systems LLC
Cirtec Medical Systems LLC Medical SpecialtiesHealth Technology Cirtec Medical Systems LLC provides outsourced design and manufacturing services for neuro-stimulation and cardiovascular devices. Its services include products management, design and development, device assemble and product transfers. The company was founded by Laurence S. Derose, Merwin Jerry Hansen and Michael Forman in 2009 and is headquartered in Los Gatos, CA. | Medical Specialties | Director/Board Member | |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Biotechnology | President Chief Executive Officer Director/Board Member | |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Biotechnology | Chief Executive Officer | |
Eusa Pharma Europe Ltd. | President Corporate Officer/Principal | ||
Alliance Pharmaceuticals Ltd. (United Kingdom)
Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | Pharmaceuticals: Major | Chairman | |
Jazz Pharmaceuticals France Holdings SAS
Jazz Pharmaceuticals France Holdings SAS Financial ConglomeratesFinance Jazz Pharmaceuticals France Holdings SAS is a biopharmaceutical company that develops medicines. The company is headquartered in Lyon, France. | Financial Conglomerates | Corporate Officer/Principal | |
A.E.S. Engineering Ltd.
A.E.S. Engineering Ltd. Industrial MachineryProducer Manufacturing A.E.S. Engineering Ltd. designs and manufactures mechanical seals to prevent leakage of harmful liquids & gases. The company offers products to the industries such as refining, pharmaceutical, chemicals, and power generation. It was founded by Chris Rea in 1979 and is headquartered in Rotherham, UK | Industrial Machinery | Director/Board Member | |
Polyplus-transfection SA
Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member | |
Orega Biotech SAS
Orega Biotech SAS Medical/Nursing ServicesHealth Services Orega Biotech SAS provides monoclonal antibody-based immunotherapy for cancer patients. It specializes in the discovery of novel targets and the development of first-in-class monoclonal antibodies for the treatment of cancer. The company was founded by Gilles Alberici, Nathalie Bonnefoy, Jean-François Eliaou, and Armand Bensussan in 2010 and is headquartered in Écully, France. | Medical/Nursing Services | Chief Executive Officer | |
Jazz Pharmaceuticals Germany GmbH
Jazz Pharmaceuticals Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Germany GmbH is a company committed to advancing clinical knowledge through various types of research, including non-interventional studies. The company is based in Munich, Germany. The company adheres to established regulations, industry best practices, and internal policies to ensure the integrity of their sponsored research. Jazz Pharmaceuticals Germany is focused on improving patients' lives by developing and commercializing products that address unmet medical needs. The CEO of the company is Iain Robert McGill. | Pharmaceuticals: Major | Chief Executive Officer | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer | |
Aplagon Oy
Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Financial Conglomerates | Director/Board Member |
Statistics
International
United Kingdom | 21 |
France | 11 |
United States | 10 |
Germany | 5 |
Finland | 4 |
Sectoral
Health Technology | 24 |
Finance | 9 |
Commercial Services | 5 |
Consumer Services | 4 |
Electronic Technology | 3 |
Operational
Director/Board Member | 76 |
Chairman | 26 |
Independent Dir/Board Member | 22 |
Corporate Officer/Principal | 20 |
Chief Executive Officer | 15 |
Most connected contacts
Insiders | |
---|---|
Göran Albert Ando | 44 |
William W. Crouse | 29 |
James Phillips | 24 |
Ian Lobley | 19 |
Gilles Alberici | 18 |
David John Cook | 11 |
Iain Robert McGill | 9 |
Zoe Evans | 7 |
- Stock Market
- Insiders
- Brian Jackson
- Company connections